Profound expertise
With decades of experience, we leverage our deep understanding of the global pharmaceutical markets, industry trends, and technologies for our target markets.
Loading...
With decades of experience, we leverage our deep understanding of the global pharmaceutical markets, industry trends, and technologies for our target markets.
We leverage resources dynamically to support impeccable execution that is observed throughout the value chain commencing from R&D to commercialisation.
Our robust evaluation process is aimed at creating a balanced portfolio of niche and complex products for multiple geographies.
Our end-to-end delivery model is supported by a growing network of manufacturing, quality and service infrastructure globally.
STRONG TEAM WITH DEMONSTRATED DELIVERY FROM CONCEPT TO APPROVAL
PRIMARY FOCUS ON LIQUID INJECTABLES, NANO EMULSIONS AND DRUG/DEVICE COMBINATIONS
SEVERAL FORMULATIONS AND DOSAGE FORMS ARE FIRST-IN-THE-WORLD
VALUE CREATION THROUGH INNOVATION AND IP PROTECTION
We have a strong understanding of the regulatory and clinical requirements across the globe.
Capabilities from complex analytical techniques to the characterisation of product-specific attributes & API sameness.
Aligning API characteristics with dosage and delivery forms.
Portfolio to address un/undermet needs of the healthcare professionals and patients around the world
Innovation targeted at new indications to improve therapeutic outcomes and novel dosage forms to improve compliance and/or safety
Harnessing power of in-vitro models and analytical science for abridged clinical/regulatory pathways
IN-HOUSE DEVELOPMENT of complex, critical or low availability APIs, ensuring long term cost competitiveness and supply chain continuity
Our APIs are predominantly manufactured at EU GMP, AND USFDA ACCREDITED SITES
Injectables
Topicals (including oncology and hormonals)
Complex oral solids, liquids and suspensions
Drug-Device Combinations and Peptides
Non-Sterile |
Sterile |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oral solid |
Semi solid |
Hi-Pot. Semi solid |
Suppositoria |
Liquid |
Onco Oral solid |
Cephalosporins |
Mono-bactam |
Onco Lyo |
Onco Liq |
Liquid |
Lyo |
Bags |
|||
Latina Pharma SPAItaly |
|||||||||||||||
Kavis Pharma LLCUSA |
|||||||||||||||
Pharma Pack LTDHungary |
Distribution hub, late-stage customization and serialization for global markets |
Current capabilities
Planned in 2024-2025